Tanya Froehlich, MD, MS, is a developmental-behavioral pediatrician whose research focuses on attention-deficit/hyperactivity disorder (ADHD). Her publications have investigated the prevalence of ADHD, ADHD medication use, and preschool psychotropic medication use. She also studies the contribution of environmental exposures (e.g., lead, tobacco, and pesticides) to ADHD etiology, and has served as co-investigator on a National Institute of Environmental Health Sciences R01 grant examining the effects of pyrethroid pesticide exposure on ADHD symptoms. In addition, Dr. Froehlich is working to identify predictors of ADHD medication response, and received a National Institute of Mental Health (NIMH) K23 Award to investigate this topic. Currently, she is the principal investigator on an NIMH-funded R01 aimed at characterizing effects of abrupt methylphenidate discontinuation, including evaluating genetic and phenotypic moderators of effect.
In addition, Dr. Froehlich has a strong interest in interprofessional training and mentoring. She is site principal investigator for a state-funded grant whose mission is train professionals from a variety of disciplines to provide enhanced care for families on Ohio Medicaid, with a special emphasis on care of developmental and mental health conditions. Dr. Froehlich is also supervisor for a Leadership Education in Neurodevelopmental Disabilities (LEND) interdisciplinary project which focuses on elucidating the needs of families in homeless shelters. Furthermore, Dr. Froehlich serves as associate director of the Developmental and Behavioral Pediatrics Fellowship as well as the director of research training for the Cincinnati Children’s Division of Developmental and Behavioral Pediatrics.
Associate Professor, UC Department of Pediatrics
Developmental and Behavioral Pediatrics, Autism, Attention Deficit Hyperactivity Disorder ADHD, Developmental and Behavioral Pediatrics, Attention Deficit Hyperactivity Disorder ADHD